COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AstraZeneca/Oxford)

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

Read the full article here

Related Articles